Volcano Announces Preliminary Results from the ADVISE II Trial
May 23, 2013 at 05:52 AM EDT
Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced preliminary results from the ADVISE (Adenosine Vasodilator Independent Stenosis Evaluation) II trial during the hot line late breaking clinical
